TSC2 and pancreatic neuroendocrine tumor: Mutation and loss of function of TSC1 and/or TSC2 have also been shown to occur consistently in a variety of sporadic cancers including bladder, kidney, pancreatic neuroendocrine tumors, and PEComa.